Similar articles

• Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids.

  Korenblat P, Kerwin E, Leshchenko I, Yen K, Holweg CTJ, Anzures-Cabrera J, Martin C, Putnam WS, Governale L, Olsson J, Matthews JG. Korenblat P, et al. Respir Med. 2018 Jan;134:143-149. doi: 10.1016/j.rmed.2017.12.006. Epub 2017 Dec 13. Respir Med. 2018. PMID: 29413502 Clinical Trial.
• Th17 immunity in children with allergic asthma and rhinitis: a pharmacological approach.

  Albano GD, Di Sano C, Bonanno A, Riccobono L, Gagliardo R, Chanez P, Gjomarkaj M, Montalbano AM, Anzalone G, La Grutta S, Ricciardolo FL, Profita M. Albano GD, et al. PLoS One. 2013;8(4):e58892. doi: 10.1371/journal.pone.0058892. Epub 2013 Apr 3. PLoS One. 2013. PMID: 23573194 Free PMC article.
• [Zafirlukast therapy of patients with mild-to-moderate bronchial asthma].

  Naményi M, Puha K, Pánczél G, Mikó P, Fäller K, Dér K. Naményi M, et al. Orv Hetil. 1999 Jun 13;140(24):1353-6. Orv Hetil. 1999. PMID: 10439636 Clinical Trial. Hungarian.
• [Strategies for prescription of inhaled corticosteroids in mild-to-moderate asthma].

  Beurnier A, Humbert M. Beurnier A, et al. Rev Mal Respir. 2021 Jun;38(6):638-645. doi: 10.1016/j.rmr.2021.04.008. Epub 2021 May 20. Rev Mal Respir. 2021. PMID: 34024646 Review. French.
• The role of budesonide in adults and children with mild-to-moderate persistent asthma.

  Banov CH. Banov CH. J Asthma. 2004 Feb;41(1):5-17. doi: 10.1081/jas-120026092. J Asthma. 2004. PMID: 15046373 Review.